CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Heska Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Heska Corp
3760 Rocky Mountain Ave
Phone: (970) 493-7272p:970 493-7272 LOVELAND, CO  80538-7084  United States Fax: (970) 619-3003f:970 619-3003

This company was Merged or Acquired on 6/13/2023.
This company ceased filing statements with the SEC on 6/23/2023.
The Company was acquired by Antech Diagnostics, Inc., a subsidiary of Mars, Incorporated
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Heska Corporation sells, manufactures, markets and supports diagnostic and specialty products and solutions for veterinary practitioners. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The Company has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202312/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Scott W.Humphrey 52 10/1/2018 6/13/2017
President, Chief Executive Officer, Director Kevin S.Wilson 51 1/1/2017 2/24/2013
Chief Financial Officer, Executive Vice President Catherine I.Grassman 47 5/6/2019 11/30/2017
8 additional Officers and Directors records available in full report.

Business Names
Business Name
BioTech Laboratories U.S.A. LLC
CVM Companies
CVM Ecografía, S.L.
9 additional Business Names available in full report.

General Information
Number of Employees: 808 (As of 12/31/2022)
Outstanding Shares: 10,913,754 (As of 4/26/2023)
Shareholders: 177
Stock Exchange: NASD
Federal Tax Id: 770192527
Fax Number: (970) 619-3003
Email Address: hendrir@heska.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024